(Q33379949)
Statements
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group (English)
Stephen M Ansell
David J Inwards
Kendrith M Rowland
Patrick J Flynn
Roscoe F Morton
Dennis F Moore
Paul J Kurtin
Christine Allmer
Thomas E Witzig
1 reference